• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Guardant Health, Inc. - Common Stock (NQ:GH)

    143.73 -1.74 (-1.20%)
    Streaming Delayed Price Updated: 2:31 PM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 818,775
    Open 145.41
    Bid (Size) 143.53 (100)
    Ask (Size) 143.96 (100)
    Prev. Close 145.47
    Today's Range 141.33 - 147.69
    52wk Range 40.35 - 174.08
    Shares Outstanding 101,298,669
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
    From Guardant Health, Inc.
    Via Business Wire

    Performance

    YTD
    +41.3%
    +41.3%
    1 Month
    -6.5%
    -6.5%
    3 Month
    +62.4%
    +62.4%
    6 Month
    +25.3%
    +25.3%
    1 Year
    +224.7%
    +224.7%

    More News

    Read More
    News headline image
    UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    3 Mid-Cap Stocks We’re Skeptical Of
    Via StockStory
    Guardant Health Inc. (NASDAQ:GH) Shines as a Top Minervini Trend Template and High Growth Momentum Pick ↗
    Via Chartmill
    News headline image
    Why Are Guardant Health (GH) Shares Soaring Today
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Are Guardant Health (GH) Shares Soaring Today
    Via StockStory
    News headline image
    3 Russell 2000 Stocks We Approach with Caution
    Via StockStory
    Topics Energy
    News headline image
    Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗
    Via The Motley Fool
    News headline image
    1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds
    Via StockStory
    Topics Bankruptcy
    News headline image
    1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
    Via StockStory
    News headline image
    3 Unprofitable Stocks Walking a Fine Line
    Via StockStory
    Topics Electric Vehicles
    News headline image
    3 Reasons GH is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Bankruptcy Stocks Supply Chain
    News headline image
    This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders
    Via StockStory
    News headline image
    Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    3 Growth Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 of Wall Street’s Favorite Stocks Walking a Fine Line
    Via StockStory
    News headline image
    FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Why Guardant Health (GH) Stock Is Down Today
    Via StockStory

    Frequently Asked Questions

    Is Guardant Health, Inc. - Common Stock publicly traded?
    Yes, Guardant Health, Inc. - Common Stock is publicly traded.
    What exchange does Guardant Health, Inc. - Common Stock trade on?
    Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Guardant Health, Inc. - Common Stock?
    The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
    What is the current price of Guardant Health, Inc. - Common Stock?
    The current price of Guardant Health, Inc. - Common Stock is 143.73
    When was Guardant Health, Inc. - Common Stock last traded?
    The last trade of Guardant Health, Inc. - Common Stock was at 07/28/26 02:31 PM ET
    What is the market capitalization of Guardant Health, Inc. - Common Stock?
    The market capitalization of Guardant Health, Inc. - Common Stock is 14.56B
    How many shares of Guardant Health, Inc. - Common Stock are outstanding?
    Guardant Health, Inc. - Common Stock has 15B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.